Figure S1. Kaplan–Meier cumulative survival estimates for the cohort of patients with newly diagnosed SCLC. Figure S2. Kaplan–Meier cumulative survival estimates for the cohort of patients with newly diagnosed SCLC, stratified by sex. Figure S3. Kaplan–Meier cumulative survival estimates for the cohort of patients with newly diagnosed SCLC, stratified by age. Table S1. Read codes suggestive of lung cancer of small cell cancer. Table S2. Read codes and additional health data codes used to request free text comments for manual review Table S3. Case classification after manual review of patient profiles with free text comments for the sample of 400 patients. Table S4. Positive predictive value of SSc in THIN by age, sex and smoking status foll...
ICD-10 codes indicating secondary site malignancies or complications from recurrent/ progressive/ me...
Table S1. ICD-O-3 code and morphological code used in this study. Table S2. Age-specific EYLLs for 2...
SPIRIT checklist. Completed checklist of the study protocol for the development of a core outcome se...
Figure S2. KaplanâMeier analyses of overall survival (OS) of ED-SCLC patients treated with chemoth...
Figure S1. KaplanâMeier analyses of overall survival (OS) of patients without IP (blue) vs. patien...
Figure S3. Kaplan-Meier analysis of (A) progression-free survival (PFS) and (B) overall survival (OS...
Kaplan Meier curves for the validation set of ADC (Figure S9) and SCC (Figure S10) using the genomic...
Figure S1. Kaplan-Meier survival analysis stratified by histology (IDC vs. SCC) and nodal status in ...
Figure S5. Kaplan-Meier analysis of overall survival (OS) calculated from the date of initial pathol...
Table S1a. Median survival (months) by risk group and therapy sequence. Table S1b. Two year overall ...
Figure S1. Flow chart of included patients. Table S2. Table resuming patients âcharacteristics. Ta...
Figure S2. Box plot showing the distribution of TMB between the entire cohort of patients with SCLC ...
Figure S1. CTC count as a continuous variable in relation to presence of CTC clusters. (PDF 182 kb
Table S1. Selection of contacted national population-based cancer registries in Europe. Table S2. Ge...
OPCS codes identified for primary presentation and investigation: Table listing biopsy OPCS codes, o...
ICD-10 codes indicating secondary site malignancies or complications from recurrent/ progressive/ me...
Table S1. ICD-O-3 code and morphological code used in this study. Table S2. Age-specific EYLLs for 2...
SPIRIT checklist. Completed checklist of the study protocol for the development of a core outcome se...
Figure S2. KaplanâMeier analyses of overall survival (OS) of ED-SCLC patients treated with chemoth...
Figure S1. KaplanâMeier analyses of overall survival (OS) of patients without IP (blue) vs. patien...
Figure S3. Kaplan-Meier analysis of (A) progression-free survival (PFS) and (B) overall survival (OS...
Kaplan Meier curves for the validation set of ADC (Figure S9) and SCC (Figure S10) using the genomic...
Figure S1. Kaplan-Meier survival analysis stratified by histology (IDC vs. SCC) and nodal status in ...
Figure S5. Kaplan-Meier analysis of overall survival (OS) calculated from the date of initial pathol...
Table S1a. Median survival (months) by risk group and therapy sequence. Table S1b. Two year overall ...
Figure S1. Flow chart of included patients. Table S2. Table resuming patients âcharacteristics. Ta...
Figure S2. Box plot showing the distribution of TMB between the entire cohort of patients with SCLC ...
Figure S1. CTC count as a continuous variable in relation to presence of CTC clusters. (PDF 182 kb
Table S1. Selection of contacted national population-based cancer registries in Europe. Table S2. Ge...
OPCS codes identified for primary presentation and investigation: Table listing biopsy OPCS codes, o...
ICD-10 codes indicating secondary site malignancies or complications from recurrent/ progressive/ me...
Table S1. ICD-O-3 code and morphological code used in this study. Table S2. Age-specific EYLLs for 2...
SPIRIT checklist. Completed checklist of the study protocol for the development of a core outcome se...